MBX-2044

· Gilead Sciences

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MBX-2044, covering 2015-05-01 to 2015-05-01. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Tolerability Study of MBX-2044 in Patients With Type 2 Diabetes [Phase 2]